CY1113205T1 - Μεθοδος για ρυθμιση ενεργοποιησης μακροφαγου - Google Patents
Μεθοδος για ρυθμιση ενεργοποιησης μακροφαγουInfo
- Publication number
- CY1113205T1 CY1113205T1 CY20121100954T CY121100954T CY1113205T1 CY 1113205 T1 CY1113205 T1 CY 1113205T1 CY 20121100954 T CY20121100954 T CY 20121100954T CY 121100954 T CY121100954 T CY 121100954T CY 1113205 T1 CY1113205 T1 CY 1113205T1
- Authority
- CY
- Cyprus
- Prior art keywords
- macrofag
- activation
- regulation
- macrophage activation
- compounds
- Prior art date
Links
- 230000004913 activation Effects 0.000 title abstract 3
- 210000002540 macrophage Anatomy 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
- 108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
- 230000006933 amyloid-beta aggregation Effects 0.000 abstract 1
- 150000001449 anionic compounds Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- -1 sulfonates Chemical class 0.000 abstract 1
- 150000003871 sulfonates Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7429598P | 1998-02-11 | 1998-02-11 | |
| US24839699A | 1999-02-10 | 1999-02-10 | |
| EP99903869A EP1054664B1 (en) | 1998-02-11 | 1999-02-11 | Method for modulating macrophage activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113205T1 true CY1113205T1 (el) | 2016-04-13 |
Family
ID=26755484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100954T CY1113205T1 (el) | 1998-02-11 | 2012-10-16 | Μεθοδος για ρυθμιση ενεργοποιησης μακροφαγου |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1054664B1 (https=) |
| JP (1) | JP4574845B2 (https=) |
| AU (1) | AU2437899A (https=) |
| CA (2) | CA2320224C (https=) |
| CY (1) | CY1113205T1 (https=) |
| DK (1) | DK1054664T3 (https=) |
| ES (1) | ES2392391T3 (https=) |
| IL (1) | IL137751A0 (https=) |
| MX (2) | MX2008014823A (https=) |
| NZ (2) | NZ568553A (https=) |
| PT (1) | PT1054664E (https=) |
| WO (1) | WO1999040909A1 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| WO1999059571A1 (en) * | 1998-05-15 | 1999-11-25 | Neurochem, Inc. | Use of amyloid inhibitors for modulating neuronal cell death |
| US6310073B1 (en) | 1998-07-28 | 2001-10-30 | Queen's University At Kingston | Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| IL146143A0 (en) * | 1999-04-28 | 2002-07-25 | Univ Kingston | Compositions and methods for treating amyloidosis |
| EP1237547A2 (en) * | 1999-07-09 | 2002-09-11 | Isis Innovation Limited | Compounds for inhibiting diseases and preparing cells for transplantation |
| EP1251837A2 (en) | 1999-12-23 | 2002-10-30 | Neurochem, Inc. | Compounds and methods for modulating cerebral amyloid angiopathy |
| US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| CN1753662A (zh) * | 2002-12-24 | 2006-03-29 | 神经化学（国际）有限公司 | 用于治疗β－淀粉状蛋白相关疾病的治疗制剂 |
| AU2003292936A1 (en) * | 2002-12-24 | 2004-07-22 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| US7244764B2 (en) | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US7253306B2 (en) | 2003-06-23 | 2007-08-07 | Neurochem (International) Limited | Pharmaceutical drug candidates and methods for preparation thereof |
| BRPI0411800A (pt) * | 2003-06-23 | 2006-08-08 | Neurochem Int Ltd | candidatos a fármacos e métodos para sua preparação |
| US7414076B2 (en) | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| BRPI0519243A2 (pt) | 2004-12-22 | 2009-01-06 | Neurochem Int Ltd | mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide |
| TW200716088A (en) * | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
| US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
| HRP20140240T4 (hr) | 2005-11-30 | 2017-02-24 | Abbvie Inc. | Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba |
| MX2008008213A (es) | 2005-12-22 | 2008-09-03 | Neurochem Int Ltd | Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias. |
| DK2089417T3 (en) | 2006-10-12 | 2015-03-23 | Bhi Ltd Partnership | Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| AU2008311367B2 (en) | 2007-10-05 | 2014-11-13 | Ac Immune S.A. | Use of anti-amyloid beta antibody in ocular diseases |
| US20120004160A1 (en) * | 2009-02-19 | 2012-01-05 | Glaxo Group Ltd. | Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| MX2012003212A (es) * | 2009-09-17 | 2012-09-07 | North Texas Medical Ass | Papel del acido n-2-hidroxi-etil-piperazina-n´-2-etano sulfonico (hepes) en el control del dolor y reversion de lesiones por desmielinizacion. |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| EP2598882B1 (en) | 2010-07-30 | 2017-07-26 | AC Immune S.A. | Safe and functional humanized antibodies for use in treating an amyloidosis |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| WO2016163886A2 (en) * | 2015-04-10 | 2016-10-13 | Clues2Cure International B.V. | Administration of taurine or an analog thereof for the treatment of nerve cell damage |
| CN109381452A (zh) * | 2017-08-11 | 2019-02-26 | 江西青峰药业有限公司 | 乙基硫酸类化合物的应用及其制备方法 |
| CN109381453A (zh) * | 2017-08-14 | 2019-02-26 | 江西青峰药业有限公司 | 乙基硫酸钾在制备用于预防或治疗炎症性疾病药物中的应用 |
| CN109394746A (zh) * | 2017-08-15 | 2019-03-01 | 江西青峰药业有限公司 | 乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用 |
| US20250345298A1 (en) | 2022-04-28 | 2025-11-13 | Alzheon, Inc. | Apoe4 correctors and methods of use |
| AU2023403257A1 (en) | 2022-12-02 | 2025-06-12 | Alzheon, Inc. | Methods for treating neurodegenerative disorders with tramiprosate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1140049A (en) * | 1977-12-22 | 1983-01-25 | Dke J.E. Helgstran | Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid |
| US5087618A (en) * | 1982-05-18 | 1992-02-11 | University Of Florida | Redox carriers for brain-specific drug delivery |
| US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
| US5276059A (en) * | 1992-07-10 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of diseases associated with amyloid formation |
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| US5643562A (en) * | 1993-03-29 | 1997-07-01 | Queen's University Of Kingston | Method for treating amyloidosis |
| WO1994022437A2 (en) * | 1993-03-29 | 1994-10-13 | Queen's University At Kingston | Method for treating amyloidosis |
| IL134619A0 (en) * | 1997-08-18 | 2001-04-30 | Univ Kingston | Phosphono-carboxylate compounds for treating amyloidosis |
| US5869469A (en) * | 1997-08-18 | 1999-02-09 | Queen's University At Kingston | Phosphonocarboxylate compounds for treating amyloidosis |
-
1999
- 1999-02-11 CA CA002320224A patent/CA2320224C/en not_active Expired - Lifetime
- 1999-02-11 JP JP2000531161A patent/JP4574845B2/ja not_active Expired - Lifetime
- 1999-02-11 AU AU24378/99A patent/AU2437899A/en not_active Abandoned
- 1999-02-11 MX MX2008014823A patent/MX2008014823A/es active IP Right Grant
- 1999-02-11 PT PT99903869T patent/PT1054664E/pt unknown
- 1999-02-11 EP EP99903869A patent/EP1054664B1/en not_active Expired - Lifetime
- 1999-02-11 CA CA002632106A patent/CA2632106A1/en not_active Abandoned
- 1999-02-11 ES ES99903869T patent/ES2392391T3/es not_active Expired - Lifetime
- 1999-02-11 WO PCT/IB1999/000354 patent/WO1999040909A1/en not_active Ceased
- 1999-02-11 NZ NZ568553A patent/NZ568553A/en unknown
- 1999-02-11 IL IL13775199A patent/IL137751A0/xx not_active IP Right Cessation
- 1999-02-11 DK DK99903869.8T patent/DK1054664T3/da active
- 1999-02-11 MX MXPA00007815A patent/MXPA00007815A/es active IP Right Grant
- 1999-02-11 NZ NZ550199A patent/NZ550199A/en not_active IP Right Cessation
-
2012
- 2012-10-16 CY CY20121100954T patent/CY1113205T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ550199A (en) | 2008-07-31 |
| EP1054664B1 (en) | 2012-08-08 |
| CA2632106A1 (en) | 1999-08-19 |
| PT1054664E (pt) | 2012-11-02 |
| DK1054664T3 (da) | 2012-11-05 |
| WO1999040909A1 (en) | 1999-08-19 |
| ES2392391T3 (es) | 2012-12-10 |
| JP2002502871A (ja) | 2002-01-29 |
| CA2320224A1 (en) | 1999-08-19 |
| EP1054664A1 (en) | 2000-11-29 |
| JP4574845B2 (ja) | 2010-11-04 |
| IL137751A0 (en) | 2001-10-31 |
| AU2437899A (en) | 1999-08-30 |
| HK1032915A1 (en) | 2001-08-10 |
| MX2008014823A (es) | 2009-03-06 |
| CA2320224C (en) | 2008-08-12 |
| NZ568553A (en) | 2010-02-26 |
| MXPA00007815A (es) | 2002-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113205T1 (el) | Μεθοδος για ρυθμιση ενεργοποιησης μακροφαγου | |
| NO994689D0 (no) | Fremgangsmaate til aa diagnostisere psykiatriske lidelser | |
| MA24589A1 (fr) | Procede nouveau de fabrication de dispersions solides. | |
| CY1105517T1 (el) | 2-oxo-1-pyrrolidine παραγωγο και οι φαρμακευτικες του χρησεις | |
| MY126559A (en) | Fungicidal 2-methoxybenzophenones | |
| BR9609744A (pt) | Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2 | |
| ITMI951445A0 (it) | Procedimento per la produzione di carbammati aromatici | |
| ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| TR200103551T2 (tr) | Amiloid protein birikimini önleme ve amiloid tortularını görüntüleme metodu | |
| BR9915868A (pt) | Processo para a decomposição de tramadol | |
| EP1023250A4 (en) | METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE | |
| ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| ZA99939B (en) | Process for the preparation of 2-aryl-5-(perfluoroalkyl) pyrrole compounds from N-(perfluoroalkylmethyl) arylimidoyl chloride compounds. | |
| NO971972L (no) | Hydrofon, samt fremgangsmåte for fremstilling av denne | |
| BR9712773A (pt) | Processo para a sìntese de benzotiofenos | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| IT1261221B (it) | Procedimento per inibire la formazione di composti di decomposizione dal riscaldamento di 1,1-dicloro-1-fluoroetano. | |
| DK0735043T3 (da) | Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran | |
| NO991675D0 (no) | FremgangsmÕte for alkylering av hindrede sulfonamider | |
| DK0915858T3 (da) | Mellemprodukter til fremstilling af 2-imidazolin-5-oner | |
| EE05156B1 (et) | R-(+)-6-karboksamido-3-N-metlamino-1,2,3,4-tetrahdrokarbasooli tootmise meetod | |
| IT1290151B1 (it) | Procedimento migliorato per la produzione di 5-idrossimetiltiazolo | |
| SE9602416D0 (sv) | New forms of an organic salt of N'N-diacetylcystine | |
| MY122950A (en) | Photochromic oxazine compounds and methods for their manufacture | |
| NO20005743D0 (no) | Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider |